New deadline for Long-Acting Injectable Buprenorphine Funding Program

Washington State Health Care Authority sent this bulletin at 04/18/2025 07:55 AM PDT

April 18, 2025

Can’t access the links? Add “lnks.gd” to the allowlist of your content blocking software.

New deadline for Long-Acting Injectable (LAI) Buprenorphine Funding Program

The Health Care Authority (HCA) is accepting applications from small providers to join the LAI buprenorphine funding program.

The new deadline to submit applications is April 30, 2025.

How to apply

Small providers interested in providing LAI buprenorphine should apply for these funds by:

Completing the participating provider agreement and
Sending the signed agreement to HCA Prescription Drug Program

About the LAI buprenorphine funding program

The LAI Buprenorphine Funding Program is a ship to/bill to arrangement for small providers to stock LAI buprenorphine in their clinic. When working with a patient with an opioid use disorder, the provider can treat that individual right then, rather than expecting the patient to return to the clinic once the medication arrives. HCA is covering the cost of the medications with funds from the opioid abatement settlement. Small providers are defined as a clinic with 5 or fewer licensed prescribers that prescribe Sublocade or Brixadi, and are not owned or operated by a hospital or carceral facility.

Find out more about this program and the application process in the frequently asked questions (FAQ).

View the FAQ

About the Health Care Authority (HCA)

Functioning as both the state's largest health care purchaser and its behavioral health authority, the Washington State Health Care Authority (HCA) is a leader in ensuring Washington residents have the opportunity to be as healthy as possible.

There are three pillars of our work: Apple Health (Medicaid); the Public Employees Benefits Board (PEBB) and School Employees Benefits Board (SEBB) programs; and behavioral health and recovery. Under these pillars, HCA purchases health care, including behavioral health treatment for more than 2.7 million Washington residents and provides behavioral health prevention, crisis, and recovery supports to all Washington residents.

Please do not reply directly to this message. For more information, visit the HCA website, where you'll also find contact information.

Disclosure notice

All messages we send via GovDelivery are subject to public disclosure, as are the names and email addresses of those who sign up for email notifications.

Nondiscrimination

The Washington State Health Care Authority (HCA) complies with all applicable federal and Washington state civil rights laws and is committed to providing equal access to our services. Visit HCA’s website to view complete nondiscrimination statements.